Breath Diagnostics, Inc., a leader in breath-based molecular diagnostics powered by patented microreactor capture technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) ...
Eldorado Gold Corporation (“Eldorado” or the “Company”) today reports the Company’s financial and operational results for the fourth quarter and year ended December 31, 2025. For further information ...
The USDA announced it has granted Emergency Use Authorization (EUA) to afoxolaner chewable tablets (NexGard;Boehringer Ingelheim) for treating New World screwworm (NWS) myiasis in canines, and ...